|
rs80357509
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Spectrum of genetic variants of BRCA1 and BRCA2 in a German single center study.
|
28324225 |
2017 |
|
rs80357509
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing.
|
26681312 |
2016 |
|
rs80357509
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer.
|
25452441 |
2015 |
|
rs80357509
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations.
|
24285858 |
2014 |
|
rs80357509
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer.
|
23192404 |
2013 |
|
rs80357509
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Massive parallel amplicon sequencing of the breast cancer genes BRCA1 and BRCA2: opportunities, challenges, and limitations.
|
21305653 |
2011 |
|
rs80357509
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.
|
20609468 |
2010 |
|
rs80357509
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control.
|
23199084 |
2010 |
|
rs80357509
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups.
|
18159056 |
2007 |
|
rs80357509
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting.
|
16683254 |
2006 |
|
rs80357509
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families.
|
15642173 |
2005 |
|
rs80357509
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
A prospective study on predictive factors linked to the presence of BRCA1 and BRCA2 mutations in breast cancer patients.
|
15955690 |
2005 |
|
rs80357509
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population.
|
11802209 |
2002 |
|
rs80357509
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
BRCA1 and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients.
|
11436123 |
2001 |
|
rs80357509
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families.
|
11597388 |
2001 |
|
rs80357509
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Detection of BRCA1 and BRCA2 mutations in breast cancer families by a comprehensive two-stage screening procedure.
|
10699917 |
2000 |
|
rs80357509
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2.
|
10188893 |
1999 |
|
rs80357509
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.
|
9667259 |
1998 |
|
rs80357509
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes.
|
9361038 |
1997 |
|
rs80357509
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families.
|
9150151 |
1997 |